<DOC>
	<DOCNO>NCT00056381</DOCNO>
	<brief_summary>Anidulafungin medicine develop treatment adult certain kind fungal infection . This study evaluate anidulafungin child adolescent fever low white blood cell count ( neutropenia ) .</brief_summary>
	<brief_title>Safety , Tolerance Pharmacokinetics Anidulafungin Immunocompromised Children Ages 2-17</brief_title>
	<detailed_description>Anidulafungin investigational drug develop intravenous treatment esophageal candidiasis , candidemia invasive fungal infection . Anidulafungin antifungal agent echinocandin class , target fungal cell wall yeast filamentous fungi .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Children age 217 year fever neutropenia . The expected duration neutropenia 10 day due cytotoxic chemotherapy aplastic anemia .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>neutropenia</keyword>
	<keyword>fever</keyword>
	<keyword>febrile neutropenia</keyword>
</DOC>